Daniel S. Kellner, MD
Dr. Kellner has been providing urologic care in the Greater New Haven area and the Shoreline since 2005. A graduate of the UConn School of Medicine, he trained at Lenox Hill Hospital in New York City as well as New York Presbyterian Hospital and Memorial-Sloan Kettering Cancer Center. He is board certified by the American Board of Urology.
Dr. Kellner offers his patients laparoscopic, robotic and other minimally invasive techniques for treating urological disease. He has expertise in robotic surgery for prostate cancer and has instructed fellow urologists in learning this technique. A large focus of his practice is men’s health issues, with a strong interest in helping men manage benign prostatic hyperplasia, also known as BPH. Dr. Kellner offers several treatment options for BPH, including office-based procedures such as Urolift, as well as several surgical treatments for BPH including TURP (Transurethral Resection of the Prostate), GreenLight Laser treatment, and HoLEP (Holmium Laser Enucleation of the Prostate). Dr. Kellner is the first urologist in Connecticut to offer HoLEP, and as of June 2022 he has completed more than 500 HoLEP procedures.
Dr. Kellner is a member of the American Urological Association and the Connecticut Urological Society. He is featured regularly on the list of “Top Doctors” by Connecticut Magazine.
Education & Training
- Urology ResidentLenox Hill Hospital (2005)
- ResidentLenox Hill Hospital (2001)
- MDUConn School of Medicine (1999)
- BSPennsylvania State University, Biology (1995)
- Board CertificationAB of Urology, Urology (2007, recertified: 2016)
- Understanding Prostate HealthNew Haven, CT, United States 2011Understanding Prostate Health
- Effective Alternatives to BPH Medical ManagementGuilford, CT, United States 2009Effective Alternatives to BPH Medical Management
- Sexual Health, What Men need to KnowGuilford, CT, United States 2008Sexual Health, What Men need to Know
- Overactive Bladder (OAB)New Haven, CT, United States 2006Overactive Bladder (OAB)
- Use of Alloderm for Closure of Intraoral Defects after Buccal Mucosal HarvestNew York, NY, United States 2005Use of Alloderm for Closure of Intraoral Defects after Buccal Mucosal Harvest
- "Long-Term Follow-Up of Buccal Mucosal Grafts for Anterior Urethral Reconstruction"Chicago, IL, United States 2003"Long-Term Follow-Up of Buccal Mucosal Grafts for Anterior Urethral Reconstruction"
- "Losartan, An Angiotensin II Receptor Antagonist, Decreases Apoptosis and Macrophage Infiltration in Unilateral Ureteral Obstruction in Rats"Chicago, IL, United States 2003"Losartan, An Angiotensin II Receptor Antagonist, Decreases Apoptosis and Macrophage Infiltration in Unilateral Ureteral Obstruction in Rats"
Honors & Recognition
|Faculty Award for Clinical Excellence||Yale Urology||2022|
|Connecticut Magazine's Top Doctors||2011, 2012, 2013, 2014|
|Sigma Xi Research Honor Society||1999|
|Phi Beta Kappa||1995|
|President of Mortar Board Senior Honor Society||1995|
|Dean's List, 7 Semesters||1995|
|Urology Clinical Operations Committee||Council Member||2019 - Present|
|Director of Urology Grand Rounds||Planning, organizing, and leading Urology Grand Rounds||2018 - Present|
Departments & Organizations
- Benign Prostatic Hyperplasia Program
- Male Reproductive Health Program
- Male Sexual Medicine Program
- Male Urology Program
- Robotic Surgery and Laparoscopy
- Stone Disease Program
- Yale Medicine